Filtered By:
Vaccination: Meningitis Vaccine

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 2865 results found since Jan 2013.

Google search behavior for meningitis and its vaccines: an infodemiological study
The internet has made significant contributions towards health education. Analyzing the pattern of online behavior regarding meningitis and vaccinations may be worthwhile. It is hypothesized that the online se...
Source: BMC Neurology - June 23, 2021 Category: Neurology Authors: John Angelo Luigi S. Perez, Adrian I. Espiritu and Roland Dominic G. Jamora Tags: Research Source Type: research

Invasive Pneumococcal Disease burden and PCV coverage in children under five in Southeast Asia: implications for India
Conclusions: Widespread PCV use could successfully reduce IPD burden in the region due to high serotype coverage by available PCVs; emphasis should be placed on increasing vaccination uptake, for every child, particularly in India. Reducing health system barriers and improving surveillance and awareness is essential to improve coverage and effectively prevent IPD morbidity and mortality particularly in at risk regions.
Source: The Journal of Infection in Developing Countries - June 29, 2021 Category: Infectious Diseases Source Type: research

Prevalence of Bacteremia in Febrile Patients With Sickle Cell Disease: Meta-Analysis of Observational Studies
Conclusions There appears to be a need to develop a risk stratification strategy to guide physicians to manage febrile patients with SCD based on factors including, but not limited to, history and clinical examination, vaccination status, use of prophylactic antibiotics, laboratory values, likely source of infection, and accessibility to health care.
Source: Pediatric Emergency Care - December 1, 2021 Category: Emergency Medicine Tags: Review Articles Source Type: research

Health actor approaches to financing universal coverage strategies for pneumococcal and rotavirus immunisation programmes in low-income and middle-income countries: a scoping review protocol
This study protocol outline a scoping review of the peer-reviewed and the grey literature, using established methodological framework for scoping review. Literature will be identified through a comprehensive search of multiple databases and grey literature. All peer-reviewed implementation research studies from the year 2002 addressing financing and universal coverage of immunisation programmes for the pneumococcal conjugated vaccine and rotavirus vaccines immunisation interventions will be included and grey literature published in/after the year 2015. For the study scope, population, concept and context are defined: Popul...
Source: BMJ Open - December 14, 2021 Category: General Medicine Authors: Ogundele, O. J., Fadel, S., Braitstein, P., Di Ruggiero, E. Tags: Open access, Global health Source Type: research

Meningococcal Vaccination and Risk of Serious Adverse Events: A Systematic Review
Conclusions Vaccination is adequate protection against meningococcal infections, with reported minimal adverse effects after immunization that do not constitute absolute contraindications to vaccination except allergic or anaphylactic reaction that needs further evaluation.
Source: Infectious Diseases in Clinical Practice - March 1, 2022 Category: Infectious Diseases Tags: Original Articles Source Type: research

Therapeutic Potential of Tralokinumab in the Treatment of Atopic Dermatitis: A Review on the Emerging Clinical Data
Clin Cosmet Investig Dermatol. 2022 Jun 3;15:1037-1043. doi: 10.2147/CCID.S267217. eCollection 2022.ABSTRACTAtopic dermatitis (AD) is a chronic inflammatory skin disease that greatly impacts patient quality of life. Type 2 cytokine interleukin (IL)-13 is integral to the pathogenesis of AD. Tralokinumab is a fully human IgG4 monoclonal antibody that specifically targets IL-13, preventing downstream signaling of inflammatory pathways that may contribute to AD. Tralokinumab was US Food and Drug administration (FDA) recently approved for the treatment of moderate to severe AD on December 28, 2021. In our review, we will explor...
Source: Clinical, Cosmetic and Investigational Dermatology - June 10, 2022 Category: Dermatology Authors: Katherine A Kelly Patrick O Perche Steven R Feldman Source Type: research

Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection
Streptococcus pneumoniae is a Gram-positive bacterium and the leading cause of bacterial pneumonia in children and the elderly worldwide. Currently, two types of licensed vaccines are available to prevent the disease caused by this pathogen: the 23-valent pneumococcal polysaccharide-based vaccine and the 7-, 10, 13, 15 and 20-valent pneumococcal conjugate vaccine. However, these vaccines, composed of the principal capsular polysaccharide of leading serotypes of this bacterium, have some problems, such as high production costs and serotype-dependent effectiveness. These drawbacks have stimulated research initiatives into no...
Source: Frontiers in cellular and infection microbiology - September 26, 2022 Category: Microbiology Source Type: research

Pneumococcal Vaccination in Rheumatology: Utilizing Nurse-Driven Protocol For Pneumococcal Vaccination in an Academic Rheumatology Clinic
CONCLUSION: It is feasible to employ a nurse-driven protocol for improving pneumococcal vaccination rates in immunosuppressed patients, despite difficulties posed by COVID-19 pandemic disruptions.PMID:36319017 | DOI:10.3899/jrheum.220771
Source: Journal of Rheumatology - November 1, 2022 Category: Rheumatology Authors: Elena K Joerns Nagendra Pokala Bonnie Bermas Joan Reisch Dan Clarie Wang Reuben Arasaratnam Puneet Bajaj Source Type: research